[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100425752":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":34,"responsibleParty":52,"collaborators":54,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group",null,"Adults patients who are scheduled to undergo treatment for a benign or malignant condition and meet the inclusion and exclusion criteria.",[13],"Device: Device: Wearable Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Device: Wearable Device","A Wearable Device will be placed on the wrist of the patient \\~30 days prior to the patient's scheduled treatment and for up to 5 years following treatment. The device will record activity in terms of steps, sleep quality, heart rate, etc.",[9],[21],{"name":22,"affiliation":5,"role":23},"Chi-Fu Jeffrey Yang","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Chi-Fu Jeffrey Yang, MD","CONTACT","617-726-5200","cjyang@mgh.harvard.edu",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Isha Mehta Warikoo, MD","857-250-1355","imehtawarikoo@mgh.harvard.edu",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-71.05977,42.35843,{"lat":46,"lon":45},[49],{"name":50,"role":27,"phone":51,"phoneExt":10,"email":29},"Chi-Fu J Yang, M.D.","814-574-8695",{"type":23,"investigatorFullName":22,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"MD",[55],{"name":56,"class":6},"Case Western Reserve University","100425752","the-role-of-wearable-devices-in-predicting-and-detecting-complications-and-adverse-events-100425752",false,"NCT04824066","The Role of Wearable Devices in Predicting and Detecting Complications and Adverse Events","Inclusion Criteria:\n\n1. Age 18 years or older\n2. Individuals scheduled to undergo one of the following surgical or non-surgical treatments: cardiothoracic surgery, orthopedic surgery, vascular surgery, colorectal surgery, pancreatic surgery, other major abdominal surgeries, treatment for chronic disease, or systemic therapy (i.e., chemotherapy, immunotherapy, or targeted therapy), radiotherapy, or ablation.\n3. Amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap).\n4. Individuals willing to provide informed consent and who have capacity for all study procedures\n\nExclusion Criteria:\n\n1. Individuals with mental incapacity and\u002For cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol.\n2. Any pregnant participant.","ALL","18 Years",{"count":66,"type":67},2400,"ESTIMATED","OBSERVATIONAL","The overarching goal of this research is to use machine learning analysis of high-resolution data-collected by wearable technology-to predict complications and poor recovery in patients undergoing treatment for benign or malignant conditions.",[71,72],"Recovery","Treatment Complication","2026-05-24",{"date":75,"type":76},"2026-05-28","ACTUAL",{"date":78,"type":76},"2021-07-10",{"date":80,"type":67},"2029-06-30",{"name":5,"class":6},1]